4.5 Article

The diuretic bumetanide decreases autistic behaviour in five infants treated during 3 months with no side effects

期刊

ACTA PAEDIATRICA
卷 99, 期 12, 页码 1885-1888

出版社

WILEY-BLACKWELL
DOI: 10.1111/j.1651-2227.2010.01933.x

关键词

Autism; Bumetanide; Chloride transport; Therapeutic actions of a diuretic

向作者/读者索取更多资源

The inhibitory transmitter GABA has been suggested to play an important role in infantile autistic syndrome (IAS), and extensive investigations suggest that excitatory actions of GABA in neurological disorders are because of a persistent increase of [Cl(-)](I). Aims: To test the effects of the chloride co-transporter NKCC1 diuretic compound Bumetanide that reduces [Cl(-)](I) on IAS. Methods: Bumetanide was administered daily (1 mg daily) during a 3 -month period and clinical and biological tests made. We used 5 standard IAS severity tests - Childhood Autism Rating Scale, Aberrant Behaviour Checklist, Clinical Global Impressions; Repetitive and Restrictive Behaviour and the Regulation Disorder Evaluation Grid. Results: We report a significant improvement in IAS with no side effects. Conclusion: Bumetanide decreases autistic behaviour with no side effects suggesting that diuretic agents may exert beneficial effects on IAS and that alterations of the actions of GABA may be efficient in IAS treatment calling for large scale randomized trials.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Neurosciences

Term or Preterm Cesarean Section Delivery Does Not Lead to Long-term Detrimental Consequences in Mice

Morgane Chiesa, Damien Guimond, Roman Tyzio, Alexandre Pons-Bennaceur, Natalia Lozovaya, Nail Burnashev, Diana C. Ferrari, Yehezkel Ben-Ari

CEREBRAL CORTEX (2019)

Article Multidisciplinary Sciences

GABAergic inhibition in dual-transmission cholinergic and GABAergic striatal interneurons is abolished in Parkinson disease

N. Lozovaya, S. Eftekhari, R. Cloarec, L. A. Gouty-Colomer, A. Dufour, B. Riffault, M. Billon-Grand, A. Pons-Bennaceur, N. Oumar, N. Burnashev, Y. Ben-Ari, C. Hammond

NATURE COMMUNICATIONS (2018)

Article Multidisciplinary Sciences

Bumetanide for autism: more eye contact, less amygdala activation

Nouchine Hadjikhani, Jakob Asberg Johnels, Amandine Lassalle, Nicole R. Zurcher, Loyse Hippolyte, Christopher Gillberg, Eric Lemonnier, Yehezkel Ben-Ari

SCIENTIFIC REPORTS (2018)

Article Neurosciences

The GABA Developmental Shift Is Abolished by Maternal Immune Activation Already at Birth

Amandine Fernandez, Camille Dumon, Damien Guimond, Roman Tyzio, Paolo Bonifazi, Natalia Lozovaya, Nail Burnashev, Diana C. Ferrari, Yehezkel Ben-Ari

CEREBRAL CORTEX (2019)

Article Multidisciplinary Sciences

Pyramidal neuron growth and increased hippocampal volume during labor and birth in autism

R. Cloarec, B. Riffault, A. Dufour, H. Rabiei, L. -A. Gouty-Colomer, C. Dumon, D. Guimond, P. Bonifazi, S. Eftekhari, N. Lozovaya, D. C. Ferrari, Y. Ben-Ari

SCIENCE ADVANCES (2019)

Article Multidisciplinary Sciences

Early alterations in a mouse model of Rett syndrome: the GABA developmental shift is abolished at birth

N. Lozovaya, R. Nardou, R. Tyzio, M. Chiesa, A. Pons-Bennaceur, S. Eftekhari, T-T Bui, M. Billon-Grand, J. Rasero, P. Bonifazi, D. Guimond, J-L Gaiarsa, D. C. Ferrari, Y. Ben-Ari

SCIENTIFIC REPORTS (2019)

Article Neurosciences

Enhanced Glutamatergic Currents at Birth in Shank3 KO Mice

Morgane Chiesa, Romain Nardou, Natalia Lozovaya, Sanaz Eftekhari, Roman Tyzio, Damien Guimond, Diana C. Ferrari, Yehezkel Ben-Ari

NEURAL PLASTICITY (2019)

Letter Psychology, Developmental

Treating Autism With Bumetanide: Are Large Multicentric and Monocentric Trials on Selected Populations Complementary?

Eric Lemonnier, Hamed Rabiei, David Makowski, Nouchine Hadjikhani, Yehezkel Ben-Ari

JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2021)

Review Clinical Neurology

Phenobarbital, midazolam, bumetanide, and neonatal seizures: The devil is in the details

Yehezkel Ben-Ari, Eric Delpire

Summary: The study shows that phenobarbital and midazolam can reduce neonatal seizures following birth asphyxia, but their effectiveness is dependent on the timing of administration; in contrast, the chloride importer antagonist has no effect on reducing seizures. However, the efficacy of drugs on seizures may be influenced by recurrent seizures.

EPILEPSIA (2021)

Article Neurosciences

Brain Volumes in Mice are Smaller at Birth After Term or Preterm Cesarean Section Delivery

Morgane Chiesa, Hamed Rabiei, Baptiste Riffault, Diana Carolina Ferrari, Yehezkel Ben-Ari

Summary: The study found that cesarean section (CS) delivery in mice is associated with reduced brain volumes, particularly in preterm CS pups. Additionally, cellular activity and apoptosis were reduced in preterm CS mice but not in term CS mice, indicating that the combination of preterm birth and CS delivery impacts early-life processes.

CEREBRAL CORTEX (2021)

Editorial Material Cell Biology

A Wholistic View of How Bumetanide Attenuates Autism Spectrum Disorders

Eric Delpire, Yehezkel Ben-Ari

Summary: Bumetanide, a specific NKCC1 cotransporter antagonist, shows potential in attenuating the severity of Autism Spectrum Disorders (ASD) and other neurodevelopmental or neurodegenerative disorders. However, its therapeutic efficacy may be challenged by the widespread expression of NKCC1 in various cell types. Additionally, disruptions in peripheral functions are linked to neurological sequels and increased incidence of the disorder. Therefore, a holistic approach considering both central and peripheral impacts may be beneficial in treating these disorders.
Article Neurosciences

A quantitative cholinergic and catecholaminergic 3D Atlas of the developing mouse brain

B. Riffault, R. Cloarec, H. Rabiei, M. Begnis, D. C. Ferrari, Yehezkel Ben-Ari

Summary: This study provides the first 3D atlases of the cholinergic and catecholaminergic systems in the mouse brain from embryonic day 12 to post-natal day 8 using tissue clearing, immunohistochemistry, lightsheet microscopy, and a multiresolution registration technique. The findings show a logarithmic scale increase of choline acetyltransferase and tyrosine hydroxylase positive neurons from E18 to P8 in several brain structures. Moreover, there are abrupt modifications in the developmental trajectory of many brain structures during the transition from E18 to P0.

NEUROIMAGE (2022)

Editorial Material Neurosciences

GABA Signaling: Therapeutic Targets for Neurodegenerative and Neurodevelopmental Disorders

Enrico Cherubini, Yehezkel Ben-Ari

BRAIN SCIENCES (2023)

Article Cell Biology

Striatal dual cholinergic /GABAergic transmission in Parkinson disease: friends or foes?

Natalia Lozovaya, Yehezkel Ben-Ari, Constance Hammond

CELL STRESS (2018)

暂无数据